Literature DB >> 16098829

Role of Rho-kinase in regulation of insulin action and glucose homeostasis.

Noboru Furukawa1, Pat Ongusaha, Wan Jin Jahng, Kazushi Araki, Cheol Soo Choi, Hyo-Jeong Kim, Yong Hee Lee, Kozo Kaibuchi, Barbara B Kahn, Hiroaki Masuzaki, Jason K Kim, Sam W Lee, Young-Bum Kim.   

Abstract

Accumulating evidence indicates an important role for serine phosphorylation of IRS-1 in the regulation of insulin action. Recent studies suggest that Rho-kinase (ROK) is a mediator of insulin signaling, via interaction with IRS-1. Here we show that insulin stimulation of glucose transport is impaired when ROK is chemically or biologically inhibited in cultured adipocytes and myotubes and in isolated soleus muscle ex vivo. Inactivation of ROK also reduces insulin-stimulated IRS-1 tyrosine phosphorylation and PI3K activity. Moreover, inhibition of ROK activity in mice causes insulin resistance by reducing insulin-stimulated glucose uptake in skeletal muscle in vivo. Mass spectrometry analysis identifies IRS-1 Ser632/635 as substrates of ROK in vitro, and mutation of these sites inhibits insulin signaling. These results strongly suggest that ROK regulates insulin-stimulated glucose transport in vitro and in vivo. Thus, ROK is an important regulator of insulin signaling and glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16098829     DOI: 10.1016/j.cmet.2005.06.011

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  78 in total

1.  In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes.

Authors:  Kwang-Hoon Chun; Kang-Duk Choi; Dae-Ho Lee; Yoonshin Jung; Robert R Henry; Theodore P Ciaraldi; Young-Bum Kim
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-12-28       Impact factor: 4.310

Review 2.  Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.

Authors:  Katsutaro Morino; Kitt Falk Petersen; Gerald I Shulman
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

3.  Increased Rho kinase activity in a Taiwanese population with metabolic syndrome.

Authors:  Ping-Yen Liu; Jyh-Hong Chen; Li-Jen Lin; James K Liao
Journal:  J Am Coll Cardiol       Date:  2007-04-02       Impact factor: 24.094

Review 4.  Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.

Authors:  Naoki Sawada; James K Liao
Journal:  Antioxid Redox Signal       Date:  2013-09-24       Impact factor: 8.401

Review 5.  Rho-kinase: regulation, (dys)function, and inhibition.

Authors:  Ehsan Amin; Badri Nath Dubey; Si-Cai Zhang; Lothar Gremer; Radovan Dvorsky; Jens M Moll; Mohamed S Taha; Luitgard Nagel-Steger; Roland P Piekorz; Avril V Somlyo; Mohammad R Ahmadian
Journal:  Biol Chem       Date:  2013-11       Impact factor: 3.915

6.  Attenuation of obesity-induced insulin resistance in mice with heterozygous deletion of ROCK2.

Authors:  H Soliman; J N Varela; V Nyamandi; M Garcia-Patino; G Lin; G R Bankar; Z Jia; K M MacLeod
Journal:  Int J Obes (Lond)       Date:  2016-05-10       Impact factor: 5.095

7.  Protein kinase N2 regulates AMP kinase signaling and insulin responsiveness of glucose metabolism in skeletal muscle.

Authors:  Maxwell A Ruby; Isabelle Riedl; Julie Massart; Marcus Åhlin; Juleen R Zierath
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-07-18       Impact factor: 4.310

8.  ROCK1 isoform-specific deletion reveals a role for diet-induced insulin resistance.

Authors:  Seung-Hwan Lee; Hu Huang; Kangduk Choi; Dae Ho Lee; Jianjian Shi; Tiemin Liu; Kwang Hoon Chun; Ji A Seo; Ines S Lima; Janice M Zabolotny; Lei Wei; Young-Bum Kim
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-10       Impact factor: 4.310

9.  Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout.

Authors:  Lin Yao; Surabhi Chandra; Haroldo A Toque; Anil Bhatta; Modesto Rojas; Ruth B Caldwell; R William Caldwell
Journal:  Cardiovasc Res       Date:  2012-12-17       Impact factor: 10.787

10.  Protein kinase C-zeta phosphorylates insulin receptor substrate-1, -3, and -4 but not -2: isoform specific determinants of specificity in insulin signaling.

Authors:  Sihoon Lee; Edward G Lynn; Jeong-A Kim; Michael J Quon
Journal:  Endocrinology       Date:  2008-01-17       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.